drugset

drugset / Trial / NCT00015340

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

NCT00015340 ↗

Phase 4 Completed 582 enrolled National Institute on Drug Abuse (NIDA) New York MDRU · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is the safety and efficacy of Buprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.

Timeline

Start: 1999-08
Primary completion: 2001-08
Completion: 2001-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Buprenorphine/Naloxone	Unknown	—	—

Indications